Who owns Zynerba Pharmaceuticals?

Tip: Access positions for across all investors

Analyze quarterly positions in Zynerba Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Zynerba Pharmaceuticals stock

Who bought or sold Zynerba Pharmaceuticals this quarter?

There are no current stakeholders of Zynerba Pharmaceuticals.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Zynerba Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Beryl Capital Management Sep 2023 4.9M $6.2M
Highbridge Capital Management Sep 2023 2.3M $2.9M
CSS Sep 2023 482k $615k
Millennium Management Sep 2023 325k $413k
Jane Street Sep 2023 283k $360k
Crystalline Management Sep 2023 231k $294k
Penserra Capital Management Sep 2023 221k $280k
Hrt Financial Sep 2023 203k $258k
PenderFund Capital Management Sep 2023 123k $213k
Gts Securities Sep 2023 120k $153k
Fifth Lane Capital Sep 2023 100k $127k
Charles Schwab Investment Management Sep 2023 38k $48k
Jpmorgan Chase & Co Sep 2023 21k $27k
UBS Group Sep 2023 20k $26k
Advisor Group Holdings Sep 2023 16k $21k
King Wealth Management Sep 2023 16k $20k
Virtu Financial Sep 2023 13k $17k
National Asset Management Sep 2023 13k $16k
Key FInancial Sep 2023 7.5k $9.6k
Wells Fargo & Company Sep 2023 2.5k $3.1k
Rhumbline Advisers Sep 2023 805.00 $1.0k
Royal Bank of Canada Sep 2023 315.00 $0
Bank of America Corporation Sep 2023 282.00 $360.960000
Harbour Investments Sep 2023 100.00 $128.000000
Creative Planning Sep 2023 100.00 $128.000000